DUPONT CAPITAL MANAGEMENT CORP - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 32 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$8,333
+316.6%
33,3320.0%0.00%
Q3 2022$2,000
-33.3%
33,3320.0%0.00%
Q2 2022$3,000
-57.1%
33,3320.0%0.00%
Q1 2022$7,000
-65.0%
33,3320.0%0.00%
-100.0%
Q4 2021$20,000
+5.3%
33,3320.0%0.00%0.0%
Q3 2021$19,000
-40.6%
33,3320.0%0.00%0.0%
Q2 2021$32,00033,3320.00%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Athanor Capital, LP 39,251$380,0000.05%
Radcliffe Capital Management, L.P. 66,666$649,0000.02%
Arena Capital Advisors, LLC- CA 100,299$62,0000.01%
Exos Asset Management LLC 15,100$9,0000.01%
MARSHALL WACE, LLP 108,584$1,057,0000.00%
MMCAP International Inc. SPC 77,425$48,0000.00%
GABELLI & Co INVESTMENT ADVISERS, INC. 21,896$14,0000.00%
Atalaya Capital Management LP 13,333$8,0000.00%
SUVRETTA CAPITAL MANAGEMENT, LLC 100,000$62,0000.00%
FIR TREE CAPITAL MANAGEMENT LP 49,997$29,0000.00%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders